Disruptive, Impulse-Control, and Con duct Disorders . . . . . . . . 461
Substance-Related and Addictive Disord ers . . . . . . . . . . . . . . . 481
Neurocognitive Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 591
Personality Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 645
Paraphilic Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 685
Other Mental Disorders  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 707
Medication-Induced Movement Disorders 
and Other Adverse Effects of  Medication  . . . . . . . . . . . . . . . . 709
Other Conditions That May Be a Fo cus of Clinical Attention . . 715
 Section III
Emerging Measures and Models
Assessment Measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 733
Cultural Formulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 749
Alternative DSM-5 Model for Personality Disorder s . . . . . . . . . 761